Become A Featured Company

Helix TCS Inc. Releases Pro-Forma Financial Results for Recent Merger with BioTrackTHC

Ryan Allway

August 15th, 2018

News

Helix TCS, Inc. (OTCQB:HLIX) (the “Company”), is pleased to announce that it has released its 8-K/A disclosing the pro-forma financial statements for the Company’s previously reported merger with Bio-Tech Medical Software, Inc. dba BioTrackTHC (“BioTrack”), which closed on June 1, 2018.

Below is a table summarizing the key financial metrics of the combined enterprise had they been merged as of January 1, 2017:

“On a pro forma basis, the merger with BioTrack has tripled Helix’s consolidated revenues while adding a leading seed-to-sale compliance software provider to our portfolio,” commented Scott Ogur, Chief Financial Officer of Helix TCS. “Our strategic plan has been to utilize M&A transactions that align Helix’s services and capabilities to provide our clients with the integrated operating environments they require to be successful in the legal cannabis industry.”

On August 7, 2018, approximately two months after closing the merger with BioTrack, the Company announced the acquisition of Engeni S.A., a software development firm located in Argentina. As previously disclosed, the Engeni acquisition will support software development in critical applications across business lines, to include BioTrack and Cannabase, by expanding in-house capabilities with an experienced team of technology executives and programmers as we continue to execute on our strategy.
Expanding upon the details disclosed in the Helix TCS, Inc. press release dated August 7, 2018, the Company would like to add that the acquisition of Engeni S.A. was facilitated through the issuance of 366,700 restricted common shares of Helix TCS, Inc. at deal closing, with the potential for the Engeni S.A. management team, to earn up to 733,300 additional restricted common shares of Helix TCS, Inc. plus $100,000 cash.

The Engeni S.A. team has already begun work on the next innovations of BioTrack’s software, with key BioTrack programming executives relocating to Argentina to ensure that the detailed feedback from the customer base is translated fully into functionality that cannabis industry clients want and need.

“The Helix leadership team has extensive experience operating in emerging and frontier markets, as well as assisting in the integration of software companies in optimizing development of their products,” commented Helix TCS, Inc. Chief Executive Officer Zachary Venegas. “The Engeni transaction empowers BioTrack’s ability to continue to support and improve its current OS keeping up with the ever-changing needs of the evolving industry.”

“Given our strong position in both the government and commercial segments of the seed-to-sale software market, we have a constant flow of feedback from users. We are excited to deploy additional resources to meet more of our users’ demands while ensuring the secure and powerful nature of our technology is unchanged,” concluded Patrick Vo, Chief Executive Officer of BioTrackTHC.

About Helix TCS

Helix TCS, Inc. (OTCQB:HLIX) is a premier provider of integrated operating environment solutions for the legal cannabis industry. Helix provides a proprietary software suite and partnership platform to the legal cannabis industry, helping clients manage inventory and supply costs and bespoke monitoring and transport solutions. Helix provides clients in the legal cannabis industry high standard security operations, including transportation, armed and unarmed guarding, training, investigation, and special services.

About BioTrackTHC
Bio-Tech Medical Software, Inc., through its BioTrackTHC division, develops and provides effective, cutting-edge technology solutions for the emerging medical and recreational cannabis industry. Visit www.biotrack.com/ for more information, email sales@biotrackthc.com or call 1-800-797-4711 to order software. Follow us on Facebook, Twitter, and LinkedIn for important updates and relevant industry news. BioTrackTHC currently holds 9 government contracts and operates across 30 states, D.C., Jamaica, Australia, Puerto Rico and Canada. Bio-Tech Medical Software, Inc. is a wholly-owned subsidiary of Helix TCS Inc. (OTCQB:HLIX).
About Engeni

Engeni, SA is a software development firm that provides software solutions for small and medium businesses. The company serves clients throughout the Americas including Argentina, Mexico, Peru and the United States. Engeni leverages the latest developments in technology to deliver maximum value to the small and medium business market. Engeni, S.A. is a wholly-owned subsidiary of Helix TCS Inc. (OTCQB:HLIX).

Forward-Looking Statements

Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: our ability to fund our operations and pay any outstanding debt; fluctuations in our financial results; general economic risks; the volatile nature of the market for our products and services and other factors that could impact our anticipated growth; our ability to manage our growth; changes in laws and regulations regarding the cannabis industry and service providers in the cannabis industry; reliance on key personnel; our ability to compete effectively; security and other risks associated with our business; intellectual property risks; and other risk factors set forth from time to time in our SEC filings. Helix TCS assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading